BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19730362)

  • 1. Revisiting the immunophenotype of nephrogenic adenoma.
    Fromont G; Barcat L; Gaudin J; Irani J
    Am J Surg Pathol; 2009 Nov; 33(11):1654-8. PubMed ID: 19730362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
    Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
    Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
    Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic adenoma of the urinary tract: a review.
    Alexiev BA; LeVea CM
    Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
    McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
    Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
    Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
    Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant expression of AMACR in many distinct tumour types.
    Went PT; Sauter G; Oberholzer M; Bubendorf L
    Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic adenoma: an update on an innocuous but troublesome entity.
    Rahemtullah A; Oliva E
    Adv Anat Pathol; 2006 Sep; 13(5):247-55. PubMed ID: 16998318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
    Skinnider BF; Oliva E; Young RH; Amin MB
    Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
    Adley BP; Yang XJ
    Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
    Hansel DE; Nadasdy T; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-methyl CoA racemase expression in renal cell carcinomas.
    Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
    Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.